Trevena, Inc. to Participate in the Following November Virtual Investor Conferences

--

Guggenheim Healthcare Talks - 2nd Annual Neuro/Immunology Day Conference
November 16^th

Stifel Virtual Healthcare Conference
November 18^th

^--

CHESTERBROOK, Pa., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that management will participate in the following conferences in the month of November and invites investors to participate by webcast. Please see additional details below:

Guggenheim Healthcare Talks - 2nd Annual Neuro/Immunology Day
	Date:	Monday, November 16th, 2020
	Format:	One-on-One meetings with Trevena Management &
		Analyst-moderated panels
	Attendees:	Carrie Bourdow, President & CEO
		Barry Shin, Senior Vice President & Chief Financial Officer
Stifel Virtual Healthcare Conference
	Date:	Wednesday, November 18th, 2020
	Format:	Corporate Presentation
	Time:	4:40 - 5:10 pm Eastern Time
	Attendees:	Carrie Bourdow, President & CEO
		Barry Shin, Senior Vice President & Chief Financial Officer
		Mark A. Demitrack, MD, Senior Vice President & Chief Medical Officer

Any replay or webcast will be made available when possible, via the Events page of the Investors section on the Company’s website at www.Trevena.com.